One Stock This Week Amazed Me Intercept Pharmaceuticals Inc(Nasdaq:

[dkc]

narsayya nuvvu great.

Kani nenu oka freind ni chusa

 

athanu

 

1) FDIC lo approve kaa boye drugs ni vati companies ni chaduvuthadu

2) Approve authunnai results ki vellayi ane time lo konni konesthadu

 

 

ee case adhi kadhu.

 

They improved already existing drug which can make your liver function normally. and hype is  there is no need for transplantation anta mama.

 

hmm.. okay. Study chesi konte okay. 

[Krish]

narsayya nuvvu great.

Kani nenu oka freind ni chusa

 

athanu

 

1) FDIC lo approve kaa boye drugs ni vati companies ni chaduvuthadu

2) Approve authunnai results ki vellayi ane time lo konni konesthadu

 

 

ee case adhi kadhu.

 

They improved already existing drug which can make your liver function normally. and hype is  there is no need for transplantation anta mama.

 

yeah naak telsiname...last yr...'Roche' shares kondi...after the news of FDA approval for one drug....yes after that their share gone up 30%

[bujjulu]

yeah naak telsiname...last yr...'Roche' shares kondi...after the news of FDA approval for one drug....yes after that their share gone up 30%

ee case 30 % kadhu mama

oka 5 yrs lo jaraganidhi ante

 

70$ unna share eeroju 440$ ki vellindhi in just two days

thrusday and friday

[coca-cola]

wolf of the wall street !! hmm

[dkc]

wolf of the wall street !! hmm

 

haha.. cinema choosi mosapoku..

[bujjulu]

hmm.. okay. Study chesi konte okay. 

inka dhanni emi kontamu bhayya

already peaks lo undhi apple ki Google ki FB ki rani speed tho velthundhi

[coca-cola]

haha.. cinema choosi mosapoku..

anthaa maaayyaa we r just aaata lo arrati pandu lanti vallammm!

[dkc]

inka dhanni emi kontamu bhayya

already peaks lo undhi apple ki Google ki FB ki rani speed tho velthundhi

 

yeah.. ippudu konadam waste ee.

 

Dhooram ga undadam manchide.. 

 

long term investment ga aithe okay.. Manchi dividend iche company ni ennukovachu. Atleast 5-6 yrs hold chese laa. Kaani ippudu dividend returns chaala daarunanga unnayi. Profits are at all time low.

 

The only people who are investing in this are the big shots with free fed money at their disposal.. They hope others will follow suit and they can dump their stocks on them..

 

If you can find out who's buying this particular stock, it's easy to predict what will happen.. but its probably illegal. Rajat Gupta went to Jail for it, at the same time several white brokers roam free spending a lot of time with hookers. :P

 

Just konukkoni.. devudini nammukovadam better.

[Krish]

ee case 30 % kadhu mama

oka 5 yrs lo jaraganidhi ante

 

70$ unna share eeroju 440$ ki vellindhi in just two days

thrusday and friday

 

that's fishy man....big boys manipulation emo!!

[bujjulu]

anthaa maaayyaa we r just aaata lo arrati pandu lanti vallammm!

[media]http://www.youtube.com/watch?v=opGMAUWDcUk[/media]

[coca-cola]

http://www.youtube.com/watch?v=3S2CwCBsz4E 

 

 

 

 

hmm! rajini  &D_@@  &D_@@  &D_@@  &D_@@  &D_@@

[bujjulu]

 

Intercept's OCA drug linked with worsened cholesterol levels

Jan 12 2014, 05:48

 

 

• Patients who received Intercept Pharmaceuticals' (ICPT) beticholic acid (OCA) for the treatment of NASH in a trial for the chronic liver disease experienced increased bad cholesterol and lower good cholesterol, the NIH said after the close on Friday in a statement to the WSJ.
• The NIH said it was releasing the information to give "broader context" to its earlier findings that OCA showed a "highly statistically significant improvement" in measures of liver health vs. those who received a placebo
• Intercept didn't mention cholesterol abnormalities in two statements it put out on Thursday, nor in a subsequent analyst call. While the NIH told Intercept earlier in the week that patients had experienced "lipid effects," it failed to furnish Intercept with details. "We had no concrete data with respect to lipids," CEO Mark Pruzanski said.
• Pruzanski told the WSJ that previous studies have shown that OCA can raise lipid levels, and it was already "very public" that OCA "impacts lipid metabolism."
• Intercept's shares skyrocketed 516% on Thursday and Friday to $445.83 following news of the early ending of the study.

 

[pavan_613]

Pharma segments chala thakkuva untay ila !!! Antha luck


FDA approve kakapothey arm lick avudhhi

[Spartan]

check medbox...(MDBX).. 

[psycopk]

asalu itlaanti novel product company stock konadam entha risk oo telusa neeku?

 

Most of them 2-3 yrs lo fut avuthaayi..

 

Idemanna book cricket laaga anukunnava?

 

btw, nee experience ela unindhi stock market lo? net gains aa losses aa?

neeku good to invest anipinchi napudu koncham pm petu mayya... nenu konta..